Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Nov 26, 2018

Mylan to Present at Nasdaq's 39th London Investor Conference

Nov 20, 2018

Mylan Initiates Voluntary Nationwide Recall of 15 Lots of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Fou

Nov 20, 2018

Mylan Statement in Response to FDA Warning Letter Relating to Morgantown Plant

Nov 09, 2018

Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI™ (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease

Nov 05, 2018

Mylan Reports Third Quarter 2018 Results and Reaffirms 2018 Guidance

Oct 22, 2018

Mylan Statement: Generic Advair ANDA Status

Oct 19, 2018

Mylan Launches Hulio™ (Biosimilar Adalimumab) in Markets Across Europe

Oct 19, 2018

Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab

Oct 18, 2018

Mylan Adds to Women's Healthcare Portfolio With Launch of Generic Depo-Provera® Injection

Oct 18, 2018

Mylan to Release Third Quarter 2018 Financial Results on November 5, 2018

Pagination

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.